The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study
Open accessAbstract
CONTEXT: Epidemiological studies suggest an association between infection with Epstein-Barr virus (EBV) and risk of multiple sclerosis (MS). OBJECTIVE: To determine whether elevation in serum antibody titers to EBV viral capsid antigen (VCA), nuclear antigens (EBNA, EBNA-1, and EBNA-2), and diffuse and restricted early antigen (EA-D and EA-R) as well as to cytomegalovirus (CMV) precede the occurrence of MS. DESIGN, SETTING, AND SUBJECTS: Prospective, nested case-control study. Of 62 439 women participating in the Nurses' Health Study (aged 30-55 years in 1976) and Nurses' Health Study II (aged 25-42 years in 1989) who gave blood samples in 1989-1990 and 1996-1999, respectively, and were followed up through 1999, 144 women with definite or probable MS and 288 healthy age-matched controls were included in the analysis. MAIN OUTCOME MEASURE: Serum antibody titers to the specific EBV and CMV antigens, compared between cases and controls. RESULTS: We documented 18 cases of MS with blood collected before disease onset. Compared with their matched controls, these women had higher serum geometric mean titers (GMTs) of antibodies to EBV but not CMV. Elevations were significant for antibodies to EBNA-1 (GMT, 515 vs 203; P =.03), EBNA-2 (GMT, 91 vs 40; P =.01), and EA-D (15.9 vs 5.9; P =.04). The strongest association was found for antibodies to EBNA-2; a 4-fold difference in titers was associated with a relative risk (RR) of MS of 3.9 (95% confidence interval [CI], 1.1-13.7). The corresponding RRs were 1.6 (95% CI, 0.7-3.7) for VCA, 2.5 (95% CI, 1.0-6.3) for EBNA, 1.8 (95% CI, 1.0-3.1) for EA-D, and 1.0 (95% CI, 0.6-1.7) for CMV. Significant but generally weaker elevations in anti-EBV antibodies were also found in analyses of 126 cases of MS with blood collected after disease onset and their matched controls. CONCLUSIONS: Our results support a role of EBV in the etiology of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
(2012) · SpringerReference · doi:10.1007/springerreference_301423 · Cited by 1,192
Analysis of Longitudinal Data.
Have, T. R. T., Diggle, P. J., Liang, K.-Y., & Zeger, S. L. (1995) · Journal of the American Statistical Association · doi:10.2307/2291352 · Cited by 1,171
Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., & Rickinson, A. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1395 · Cited by 892 · cited 1×
“Antigen-specific cytotoxic T cells are massively expanded in response to primary infection and persist at high levels for several years.(5,6) Autoimmunity could result if some of these cells carry T-cell receptors that recognize self-peptides.”
BackgroundHUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
Rickinson, A. B., & Moss, D. J. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.405 · Cited by 747
de-Thé, G., Geser, A., Day, N. E., Tukei, P. M., Williams, E. H., Beri, D. P., Smith, P. G., Dean, A. G., Bornkamm, G. W., Feorino, P., et al. (1978) · Nature · doi:10.1038/274756a0 · Cited by 613
A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers
Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O’Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., & Callan, M. F. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1827 · Cited by 499
Hodgkin's Disease and Epstein-Barr Virus
Mueller, N., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich, N., Polk, B. F., & Vogelman, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201103 · Cited by 445
Hepatitis B Vaccination and the Risk of Multiple Sclerosis
Ascherio, A., Zhang, S. M., Hernán, M. A., Olek, M. J., Coplan, P. M., Brodovicz, K., & Walker, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440502 · Cited by 433
Self-citationEpstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
Li, Q., Spriggs, M. K., Kovats, S., Turk, S. M., Comeau, M. R., Nepom, B., & Hutt-Fletcher, L. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4657-4662.1997 · Cited by 319
Epstein-Barr virus and multiple sclerosis
Robinson, W. H., & Steinman, L. (2022) · Science · doi:10.1126/science.abm7930 · Cited by 310
Association between clinical disease activity and Epstein–Barr virus reactivation in MS
Wandinger, K.-P., Jabs, W., Siekhaus, A., Bubel, S., Trillenberg, P., Wagner, H.-J., Wessel, K., Kirchner, H., & Hennig, H. (2000) · Neurology · doi:10.1212/wnl.55.2.178 · Cited by 302
Cigarette Smoking and Incidence of Multiple Sclerosis
Hernan, M. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.1.69 · Cited by 292
Geographic variation of MS incidence in two prospective studies of US women
Hernán, M. A., Olek, M. J., & Ascherio, A. (1999) · Neurology · doi:10.1212/wnl.53.8.1711 · Cited by 219
Self-citationHenle, W., Henle, G., Andersson, J., Ernberg, I., Klein, G., Horwitz, C. A., Marklund, G., Rymo, L., Wellinder, C., & Straus, S. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.570 · Cited by 207
Akhyani, N., Berti, R., Brennan, M. B., Soldan, S. S., Eaton, J. M., McFarland, H. F., & Jacobson, S. (2000) · The Journal of Infectious Diseases · doi:10.1086/315893 · Cited by 171
Multiple Sclerosis and Age at Infection with Common Viruses
Hernán, M. Á., Zhang, S. M., Lipworth, L. P., Olek, M. J., & Ascherio, A. (2001) · Epidemiology · doi:10.1097/00001648-200105000-00009 · Cited by 158
Self-citationEpstein‐Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis
Larsen, P. D., Bloomer, L. C., & Bray, P. F. (1985) · Neurology · doi:10.1212/wnl.35.3.435 · Cited by 138
van Sechel, A. C., Bajramovic, J. J., van Stipdonk, M. J. B., Persoon-Deen, C., Geutskens, S. B., & van Noort, J. M. (1999) · PubMed · Cited by 123
MULTIPLE SCLEROSIS AND EPSTEIN-BARR VIRUS
Warner, H. B., & Carp, R. I. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91527-0 · Cited by 107
A case‐control study of multiple sclerosis
Operskalski, E. A., Visscher, B. R., Malmgren, R. M., & Detels, R. (1989) · Neurology · doi:10.1212/wnl.39.6.825 · Cited by 107
VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS
Compston, D. A. S., Vakarelis, B. N., Paul, E. A., McDonald, W. I., Batchelor, J. R., & Mims, C. A. (1986) · Brain · doi:10.1093/brain/109.2.325 · Cited by 97
Knox, K. K., Brewer, J., Henry, J. M., Harrington, D. J., & Carrigan, D. R. (2000) · Clinical Infectious Diseases · doi:10.1086/318141 · Cited by 97
Multiple sclerosis and antecedent infections
Marrie, R. A., Wolfson, C. M., Sturkenboom, M., Gout, O., Heinzlef, O., Roullet, E., & Abenhaim, L. (2000) · Neurology · doi:10.1212/wnl.54.12.2307 · Cited by 96
Symptomatic Epstein-Barr virus infection and multiple sclerosis.
Martyn, C. N., Cruddas, M., & Compston, D. A. S. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.2.167 · Cited by 94
Lindberg, C., Andersen, O., Vahlne, A. G., Dalton, M. E., & Runmarker, B. (1991) · Neuroepidemiology · doi:10.1159/000110248 · Cited by 90
The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis
Hafler, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8193 · Cited by 70
Lennette, E. T., Rymo, L., Yadav, M., Masucci, G. V., Merk, K., Tı́már, L., & Klein, G. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90299-u · Cited by 65
Self-citationThe significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?
Munch, M., Riisom, K., Christensen, T., Møller-Larsen, A., & HAAHR, S. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb00632.x · Cited by 58
Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation.
Hilton, D. A., Love, S., Fletcher, A. A., & Pringle, J. H. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.975 · Cited by 58
Flamand, L., & Menézes, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1784-1791.1996 · Cited by 54
Cuomo, L., Angeloni, A., Zompetta, C., Cirone, M., Calogero, A., Frati, L., Ragona, G., & Faggioni, A. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.1241 · Cited by 53
Is Epstein–Barr virus present in the CNS of patients with MS?
Morré, S. A., van Beek, J., Groot, C. J. A. D., Killestein, J., Meijer, C. J. L. M., Polman, C. H., van der Valk, P., Middeldorp, J. M., & van den Brule, A. J. C. (2001) · Neurology · doi:10.1212/wnl.56.5.692 · Cited by 26
Jabs, W. J., PAULSEN, M., Wagner, H. J., Kirchner, H., & Klüter, H. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00912.x · Cited by 21
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Cited by
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T., Barcellos, L. F., & Alfredsson, L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,185
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
Self-citationThe Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
New concepts in the immunopathogenesis of multiple sclerosis
Hemmer, B., Archelos, J. J., & Hartung, H.-P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn784 · Cited by 580
Detecting shared pathogenesis from the shared genetics of immune-related diseases
Zhernakova, A., van Diemen, C. C., & Wijmenga, C. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2489 · Cited by 551
Metadata
- Authors
- Ascherio, A., Munger, K. L., Lennette, E. T., Spiegelman, D., Hernán, M. A., Olek, M. J., Hankinson, S. E., & Hunter, D. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-12-26
- Volume
- 286
- Issue
- 24
- Pages
- 3083
- ISSN
- 0098-7484
- OpenAlex
- W2019009797
- Cited by
- 549
- References
- 37
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.